Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
Sign Up to like & getrecommendations! Published in 2020 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2020.02.030
Abstract: IL: interleukin INTRODUCTION Hypereosinophilic syndromes are rare disorders defined by persistent peripheral eosinophilia (absolute eosinophil count[1.53 10/L) plus evidence of organ involvement. They are subclassified into primary or myeloid hypereosinophilic syndromes, secondary or lymphocytic hypereosinophilic… read more here.
Keywords: hypereosinophilic syndrome; treatment; dupilumab treatment; secondary lymphocytic ... See more keywords